ITGA2 抗体 (FITC)
Quick Overview for ITGA2 抗体 (FITC) (ABIN2480707)
抗原
See all ITGA2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
产品特性
- Purified IgM conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
-
亚型
- IgM
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.1 mg/mL
-
-
-
: "Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity." in: Cancer letters, Vol. 272, Issue 2, pp. 285-95, (2008) (PubMed).
-
: "Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity." in: Cancer letters, Vol. 272, Issue 2, pp. 285-95, (2008) (PubMed).
-
- ITGA2 (Integrin alpha 2 (ITGA2))
-
别名
- CD49b
-
背景
- Synonyms: INTEGRIN ALPHA 2 CHAIN, VLA-2
-
基因ID
- 16398
-
UniProt
- Q62469
-
途径
- CXCR4-mediated Signaling Events, Smooth Muscle Cell Migration, Integrin Complex
抗原
-